Cargando…

Oral hypoglycemic agents: do the ends justify the means?

BACKGROUND: Glyburide has replaced insulin as the first line of therapy in the treatment of gestational diabetes in the United States. Glyburide and metformin therapies were reported to be comparable to insulin yet also cost-effective, patient-friendly, and potentially compliance-enhancing. Recently...

Descripción completa

Detalles Bibliográficos
Autor principal: Langer, Oded
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823678/
https://www.ncbi.nlm.nih.gov/pubmed/27057336
http://dx.doi.org/10.1186/s40748-015-0021-6